{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:58:24Z","timestamp":1697335104893},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1007\/s11936-001-0030-9","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T08:10:29Z","timestamp":1180858229000},"page":"403-413","source":"Crossref","is-referenced-by-count":1,"title":["Cardiomyopathy in children"],"prefix":"10.1007","volume":"3","author":[{"given":"Su-chiung","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"30_CR1","first-page":"1430","volume-title":"Nelson Textbook of Pediatrics","author":"D Bernstein","year":"2000","unstructured":"Bernstein D: Diseases of the myocardium. In Nelson Textbook of Pediatrics. Edited by Behrman RE, Kliegman RM, Jenson HB. Philadelphia: W B Saunders Co; 2000:1430\u20131436."},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"465A","DOI":"10.1016\/S0735-1097(01)80007-3","volume":"37","author":"SE Lipshultz","year":"2001","unstructured":"Lipshultz SE, Sleeper LA, Tomkin JA, et al.: The incidence of pediatric cardiomyopathy; the prospective pediatric cardiomyopathy registry. J Am Coll Cardiol 2001, 37:465A-466A.","journal-title":"J Am Coll Cardiol"},{"key":"30_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0031-3955(05)70119-X","volume":"46","author":"JA Towbin","year":"1999","unstructured":"Towbin JA: Pediatric myocardial disease. Pediatr Clin N Am 1999, 46:289\u2013312.","journal-title":"Pediatr Clin N Am"},{"key":"30_CR4","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/01.CIR.94.8.2021","volume":"94","author":"ML Schwartz","year":"1996","unstructured":"Schwartz ML, Cox G, Lin AE, et al.: Clinical approach to genetic cardiomyopathy in children. Circulation 1996, 94:2021\u20132038. A comprehensive review of the diagnostic approach to pediatric cardiomyopathy of genetic causes.","journal-title":"Circulation"},{"key":"30_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.83.6.580","volume":"83","author":"G Bonne","year":"1998","unstructured":"Bonne G, Carrier L, Richard P, et al.: Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 1998, 83:580\u2013593.","journal-title":"Circ Res"},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334:1349\u20131355. A report of carvedilol therapy in patients with heart failure with beneficial effect.","journal-title":"N Engl J Med"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"462A","DOI":"10.1016\/S0735-1097(01)80007-3","volume":"37","author":"E Azeka","year":"2001","unstructured":"Azeka E, Ramires JAF, Z-baid M, et al.: Delisting for heart transplantation to treatment of dilated cardiomyopathy after starting carvedilol in infants and children. J Am Coll Cardiol 2001, 37:462A.","journal-title":"J Am Coll Cardiol"},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"9A","DOI":"10.1016\/S0002-9149(99)00311-2","volume":"83","author":"M Packer","year":"1999","unstructured":"Packer M, Cohn JN: Consensus recommendations for the management of chronic heart failure. Part II. Management of heart failure. Am J Cardiol 1999, 83:9A-38A. An up-to-date and comprehensive review of heart failure management.","journal-title":"Am J Cardiol"},{"key":"30_CR9","first-page":"1248","volume":"16","author":"S Kleinert","year":"1997","unstructured":"Kleinert S, Weintraub RG, Wilkinson JL, et al.: Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997, 16:1248\u20131254.","journal-title":"J Heart Lung Transplant"},{"key":"30_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00796819","volume":"16","author":"PR Camargo","year":"1995","unstructured":"Camargo PR, Snitcowsky R, daLuz PL, et al.: Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995, 16:61\u201368.","journal-title":"Pediatr Cardiol"},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJM199811193392107","volume":"339","author":"DJ Goldstein","year":"1998","unstructured":"Goldstein DJ, Oz MC, Rose EA: Implantable left ventricular assist devices. N Engl J Med 1998, 339:1522\u20131533.","journal-title":"N Engl J Med"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1253\/jcj.62.871","volume":"62","author":"Y Takeda","year":"1998","unstructured":"Takeda Y, Yasuda S, Miyazaki S, et al.: High dose immunoglobulin G therapy for fulminant myocarditis. Jpn Cir J 1998, 62:871\u2013872.","journal-title":"Jpn Cir J"},{"key":"30_CR13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0735-1097(88)90296-3","volume":"11","author":"T Ino","year":"1988","unstructured":"Ino T, Sherwood WG, Benson LN, et al.: Cardiac manifestations in disorders of fat and carnitine metabolism in infancy. J Am Coll Cardiol 1988, 11:1301\u20131308.","journal-title":"J Am Coll Cardiol"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1067\/mhj.2000.103921","volume":"139","author":"MEM Pierpont","year":"2000","unstructured":"Pierpont MEM, Breningstall GN, Stanley CA, et al.: The role of energy metabolism defects in cardiomyopathy: from inborn errors to ischemia. Am Heart J 2000, 139:S96-S106.","journal-title":"Am Heart J"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","volume":"344","author":"ED Kakkis","year":"2001","unstructured":"Kakkis ED, Muenzer J, Tiller GE, et al.: Enzyme replacement therapy in mucopolysaccharidosis. N Engl J Med 2001, 344:182\u2013188.","journal-title":"N Engl J Med"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0735-1097(94)90844-3","volume":"24","author":"BJ Maron","year":"1994","unstructured":"Maron BJ, Isner JM, McKenna WJ: 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol 1994, 24:880\u2013885. Detailed recommendations for sport activities in patients with myocardial diseases.","journal-title":"J Am Coll Cardiol"},{"key":"30_CR17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0735-1097(99)00421-0","volume":"34","author":"I Ostman-Smith","year":"1999","unstructured":"Ostman-SmithI, Wettrell G, Riesenfeld T: A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999, 34:1813\u20131822. The beneficial effect of a high-dose beta-blocker in children with hypertrophic cardiomyopathy from three regional centers is presented.","journal-title":"J Am Coll Cardiol"},{"key":"30_CR18","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(98)00493-8","volume":"32","author":"AT Yetman","year":"1998","unstructured":"Yetman AT, Hamilton RM, Benson LN, et al.: Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998, 32:1943\u20131950.","journal-title":"J Am Coll Cardiol"},{"key":"30_CR19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0003-4975(98)00187-8","volume":"65","author":"MH Brunner-La Schonbeck","year":"1998","unstructured":"Brunner-La Schonbeck MH, Rocca HP, Vogt PR, et al.: Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myomectomy. Ann Thorac Surg 1998, 65:1207\u20131214.","journal-title":"Ann Thorac Surg"},{"key":"30_CR20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/oxfordjournals.eurheartj.a015435","volume":"18","author":"L Kappenberger","year":"1997","unstructured":"Kappenberger L, Linde C, Daubert C, et al.: Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC study group. Eur Heart J 1997, 18:1249\u20131256.","journal-title":"Eur Heart J"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","volume":"342","author":"BJ Maron","year":"2000","unstructured":"Maron BJ, Shen WK, Link MS, et al.: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000, 342:365\u2013373.","journal-title":"N Engl J Med"},{"key":"30_CR22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/01.CIR.99.3.344","volume":"99","author":"SF Nagueh","year":"1999","unstructured":"Nagueh SF, Lakkis NM, Middleton KJ, et al.: Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 1999, 99:344\u2013347.","journal-title":"Circulation"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3476(98)70228-8","volume":"133","author":"GF Cox","year":"1998","unstructured":"Cox GF, Souri M, Aoyama T, et al.: Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acylcoenzyme A dehydrogenese deficiency. J Pediat 1998, 133:247\u2013253.","journal-title":"J Pediat"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","volume":"87","author":"C Peters","year":"1996","unstructured":"Peters C, Balthazor M, Shapiro EG, et al.: Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996, 87:4894\u20134902.","journal-title":"Blood"},{"key":"30_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","volume":"336","author":"SS Kushawaha","year":"1997","unstructured":"Kushawaha SS, Fallon JI, Fuster V: Restrictive cardiomyopathy. N Engl J Med 1997, 336:267\u2013276. A comprehensive review of RCM.","journal-title":"N Engl J Med"},{"key":"30_CR26","first-page":"38","volume":"24","author":"SW Denfield","year":"1997","unstructured":"Denfield SW, Rosenthal G, Gajarski RJ, et al.: Restrictive cardiomyopathies in childhood, etiologies and natural history. Texas Heart Inst J 1997, 24:38\u201344.","journal-title":"Texas Heart Inst J"},{"key":"30_CR27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.CIR.102.8.876","volume":"102","author":"SM Rivens","year":"2000","unstructured":"Rivens SM, Kearney DL, Smith EO, et al.: Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000, 102:876\u2013882.","journal-title":"Circulation"},{"key":"30_CR28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/01.CIR.101.21.2490","volume":"101","author":"N Ammash","year":"2000","unstructured":"Ammash N, Seward J, Bailey K, et al.: Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 2000, 101:1490\u20132496.","journal-title":"Circulation"},{"key":"30_CR29","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","volume":"338","author":"ME Rothenberg","year":"1998","unstructured":"Rothenberg ME: Eosinophilia. N Engl J Med 1998, 338:1592\u20131600.","journal-title":"N Engl J Med"},{"key":"30_CR30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","volume":"30","author":"D Corrado","year":"1997","unstructured":"Corrado D, Basso C, Thiene G, et al.: Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular dysplasia: a multicenter study. J Am Coll Cardiol 1997, 30:1512\u20131520. A review of a large number of patients with ARVD.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-001-0030-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0030-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:37:30Z","timestamp":1587577050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-001-0030-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s11936-001-0030-9","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}